Albemarle Corporation (ALB) reported $6.15B of revenue for the twelve months ended Sep 30, 2026. That is up 24.4% from the year before. Revenue for fiscal 2025 was $5.14B.

Yes. Albemarle Corporation earned $681.63M in net income for the twelve months ended Sep 30, 2026, a net margin of 11.1%.

How much cash and debt does ALB have?

Albemarle Corporation reported $1.85B in cash and cash equivalents and $1.88B of debt on its most recent balance sheet in SEC filings.

How fast is ALB revenue growing?

Albemarle Corporation's revenue changed -4.4% in fiscal 2025, to $5.14B. Its compound annual growth rate was +10.4% over 5 years and +6.2% over 10 years.

What is ALB gross margin?

Albemarle Corporation's gross profit was $1.59B on $6.15B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 25.8%.

What is ALB free cash flow?

Albemarle Corporation generated $1.44B of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $1.85B less capital expenditures.

What is ALB earnings per share?

Diluted earnings per share were $4.13 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.

When did ALB last report financial results?

The latest statements here come from Albemarle Corporation's 10-Q filed on Nov 4, 2026, covering the period ended Sep 30, 2026.

Where does this ALB financial data come from?

Quantisnow builds these statements from the structured XBRL data Albemarle Corporation files with the SEC. It is provided for information only and is not investment advice.

Financials · ALB

Albemarle Corporation (ALB) financials

For the twelve months ended Sep 30, 2026, Albemarle Corporation reported $6.15B of revenue and $681.63M of net income.

Revenue, TTM: $6.15B
Revenue growth, YoY: +24.4%
Net income, TTM: $681.63M
Net margin: 11.1%
Free cash flow, TTM: $1.44B
EPS, diluted, TTM: $4.13
Cash: $1.85B
Total debt: $1.88B
P/E: 17.18
P/S: 1.90
Market cap: $11.71B

Annual revenue$5.14B

FY2016FY2025

Annual net income-$510.63M

FY2016FY2025

Annual free cash flow$692.47M

FY2016FY2025

ALB revenue and earnings growth

ALB revenueQ3 2026$1.55B

Quarter YoY: +18.8%
QoQ: -10.9%
FY YoY: -4.4%
5Y CAGR: +10.4%
10Y CAGR: +6.2%

ALB revenue was $1.55B in fiscal Q3 2026 (ended Sep 30, 2026), up 18.8% from a year earlier and down 10.9% from the prior quarter. For the full fiscal 2025 it was $5.14B, down 4.4% from fiscal 2024. Compound annual growth was +10.4% over 5 years and +6.2% over 10 years. It rose in 6 of the last 10 fiscal years.

ALB net incomeQ3 2026$296.75M

QoQ: -38.2%

ALB net income was $296.75M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$160.69M a year earlier and down 38.2% from the prior quarter. For the full fiscal 2025 it was -$510.63M, compared with -$1.18B in fiscal 2024.

ALB EPSQ3 2026$2.15

QoQ: -38.9%

ALB diluted EPS was $2.15 in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$1.72 a year earlier and down 38.9% from the prior quarter. For the full fiscal 2025 it was -$5.76, compared with -$11.20 in fiscal 2024.

ALB free cash flowQ3 2026$325.42M

Quarter YoY: +45.6%
QoQ: -49.0%
10Y CAGR: +17.9%

ALB free cash flow was $325.42M in fiscal Q3 2026 (ended Sep 30, 2026), up 45.6% from a year earlier and down 49.0% from the prior quarter. For the full fiscal 2025 it was $692.47M, compared with -$992.65M in fiscal 2024. Compound annual growth was +17.9% over 10 years. Fiscal 2025 is the highest of the 15 fiscal years on file.

Export CSV

Income statement

Income statement
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue	$5.14B	$5.38B	$9.62B	$7.32B	$3.33B	$3.13B	$3.59B	$3.37B	$3.07B	$2.68B
Cost of revenue	$4.47B	$5.31B	$8.43B	$4.25B	$2.33B	$2.13B	$2.33B	$2.16B	$1.97B	$1.71B
Gross profit	$668.72M	$62.54M	$1.19B	$3.07B	$997.97M	$994.85M	$1.26B	$1.22B	$1.11B	$970.31M
Research and development	$51.40M	$86.72M	$85.72M	$71.98M	$54.03M	$59.21M	$58.29M	$70.05M	$84.33M	$80.47M
Selling, general and admin	$550.04M	$618.05M	$910.00M	$524.14M	$441.48M	$429.83M	$533.37M	$446.09M	$450.29M	$353.76M
Operating income	-$367.08M	-$1.78B	$251.88M	$2.47B	$798.43M	$505.81M	$666.12M	$911.54M	$571.66M	$600.98M
Pre-tax income	-$552.07M	-$1.76B	$246.74M	$2.43B	$133.62M	$373.52M	$562.95M	$794.70M	$446.80M	$515.26M
Income tax	$156.88M	$87.08M	$430.28M	$390.59M	$29.45M	$54.42M	$88.16M	$144.83M	$431.82M	$96.26M
Net income	-$510.63M	-$1.18B	$1.57B	$2.69B	$123.67M	$375.76M	$533.23M	$693.56M	$54.85M	$643.67M
EPS, basic	-$5.76	-$11.20	$13.41	$22.97	$1.07	$3.53	$5.03	$6.40	$0.49	$5.73
EPS, diluted	-$5.76	-$11.20	$13.36	$22.84	$1.06	$3.52	$5.02	$6.34	$0.49	$5.68
Diluted shares	117.7M	117.5M	117.8M	117.8M	116.5M	106.8M	106.3M	109.5M	112.4M	113.2M

Balance sheet

Balance sheet
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Cash and equivalents	$1.62B	$1.19B	$889.90M	$1.50B	$439.27M	$746.72M	$613.11M	$555.32M	$1.14B	$2.27B
Receivables	$593.50M	$742.20M	$1.21B	$1.19B	$556.92M	$530.84M	$612.65M	$605.71M	$534.33M	$486.04M
Inventory	$1.18B	$1.50B	$2.16B	$2.08B	$798.62M	$750.24M	$768.98M	$700.54M	$592.78M	$450.26M
Current assets	$4.01B	$3.84B	$5.22B	$5.19B	$1.99B	$2.21B	$2.23B	$2.00B	$2.48B	$3.31B
Goodwill	$1.50B	$1.58B	$1.63B	$1.62B	$1.60B	$1.67B	$1.58B	$1.57B	$1.61B	$1.54B
Total assets	$16.37B	$16.61B	$18.27B	$15.46B	$10.97B	$10.45B	$9.86B	$7.58B	$7.75B	$8.16B
Current liabilities	$1.80B	$1.97B	$3.56B	$2.74B	$1.87B	$1.80B	$1.41B	$1.18B	$1.20B	$1.14B
Short-term debt	$74.08M	$398.02M	$625.76M	$2.13M	$389.92M	$804.68M	$187.34M	$307.29M	$422.01M	$247.54M
Long-term debt	$3.12B	$3.12B	$3.54B	$3.21B	$2.00B	$2.77B	$2.86B	$1.40B	$1.42B	$2.12B
Total debt	$3.19B	$3.52B	$4.17B	$3.22B	$2.39B	$3.57B	$3.05B	$1.71B	$1.84B	$2.37B
Total liabilities	$6.59B	$6.41B	$8.61B	$7.27B	$5.17B	$5.98B	$5.77B	$3.82B	$3.93B	$4.22B
Shareholders' equity	$9.53B	$10.20B	$9.67B	$8.19B	$5.81B	$4.47B	$4.09B	$3.76B	$3.82B	$3.94B

Cash flow

Cash flow
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Operating cash flow	$1.28B	$687.88M	$1.33B	$1.91B	$344.26M	$798.91M	$719.37M	$546.16M	$303.98M	$735.52M
Capital expenditures	$589.80M	$1.68B	$2.15B	$1.26B	$953.67M	$850.48M	$851.80M	$699.99M	$317.70M	$196.65M
Free cash flow	$692.47M	-$992.65M	-$827.96M	$646.20M	-$609.41M	-$51.56M	-$132.42M	-$153.83M	-$13.72M	$538.87M
Investing cash flow	-$146.01M	-$1.58B	-$2.56B	-$1.42B	-$666.59M	-$863.57M	-$1.66B	-$303.69M	-$357.80M	$2.92B
Financing cash flow	-$834.19M	$1.24B	$623.91M	$611.89M	$50.21M	$177.26M	$1.04B	-$786.53M	-$1.09B	-$1.58B
Dividends paid	$190.53M	$188.53M	$187.19M	$184.43M	$177.85M	$161.82M	$152.20M	$144.60M	$140.56M	$135.35M
Share repurchases	-	-	-	-	-	$0	$0	$500.00M	$250.00M	$0
Stock-based compensation	$40.27M	$32.14M	$36.55M	$30.47M	$20.12M	$22.84M	$19.68M	$15.23M	$19.40M	$17.03M
Depreciation and amortization	$658.68M	$588.64M	$429.94M	$300.84M	$254.00M	$231.98M	$213.48M	$200.70M	$196.93M	$226.17M

Key ratios

Key ratios
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue growth, YoY	-4.4%	-44.1%	31.4%	120.0%	6.4%	-12.8%	6.4%	9.9%	14.7%	-5.3%
Net income growth, YoY	-	-	-41.5%	2075.0%	-67.1%	-29.5%	-23.1%	1164.5%	-91.5%	92.2%
EPS growth, YoY	-	-	-41.5%	2054.7%	-69.9%	-29.9%	-20.8%	1193.9%	-91.4%	89.3%
Gross margin	13.0%	1.2%	12.3%	42.0%	30.0%	31.8%	35.0%	36.1%	36.0%	36.2%
Operating margin	-7.1%	-33.0%	2.6%	33.7%	24.0%	16.2%	18.6%	27.0%	18.6%	22.4%
Net margin	-9.9%	-21.9%	16.4%	36.7%	3.7%	12.0%	14.9%	20.6%	1.8%	24.0%
Free cash flow margin	13.5%	-18.5%	-8.6%	8.8%	-18.3%	-1.6%	-3.7%	-4.6%	-0.4%	20.1%
Return on equity	-5.4%	-11.6%	16.3%	32.8%	2.1%	8.4%	13.0%	18.5%	1.4%	16.3%
Return on assets	-3.1%	-7.1%	8.6%	17.4%	1.1%	3.6%	5.4%	9.1%	0.7%	7.9%
Current ratio	2.23	1.95	1.47	1.89	1.06	1.22	1.58	1.69	2.06	2.90
Debt to equity	0.33	0.34	0.43	0.39	0.41	0.80	0.75	0.45	0.48	0.60

Income statement

Income statement
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue	$1.55B	$1.74B	$1.43B	$1.43B	$1.31B	$1.33B	$1.08B	$1.23B	$1.35B	$1.43B	$1.36B	$2.36B
Cost of revenue	$1.25B	$1.15B	$927.76M	$1.23B	$1.19B	$1.13B	$920.58M	$1.09B	$1.46B	$1.44B	$1.32B	$3.06B
Gross profit	$300.72M	$590.30M	$500.97M	$197.93M	$117.61M	$196.88M	$156.30M	$138.21M	-$104.03M	-$10.58M	$38.94M	-$704.05M
Research and development	$8.17M	$3.67M	$9.17M	$12.18M	$12.67M	$12.44M	$14.10M	$20.02M	$22.40M	$20.77M	$23.53M	$22.75M
Selling, general and admin	$136.35M	$126.35M	$137.41M	$155.50M	$138.58M	$132.46M	$123.50M	$136.00M	$154.25M	$166.42M	$161.38M	$193.96M
Operating income	$148.16M	$452.94M	$233.51M	-$217.39M	-$216.99M	$47.53M	$19.76M	$4.40M	-$1.11B	-$492.61M	-$179.51M	-$849.87M
Pre-tax income	$133.22M	$441.65M	$254.19M	-$284.99M	-$239.15M	-$8.97M	-$18.97M	$76.73M	-$1.18B	-$494.13M	-$167.57M	-$920.95M
Income tax	$21.90M	$94.00M	$21.51M	$157.33M	-$30.57M	$34.09M	-$3.98M	$10.61M	$110.85M	-$30.66M	-$3.72M	$118.88M
Net income	$296.75M	$479.96M	$319.09M	-$414.18M	-$160.69M	$22.90M	$41.35M	$75.29M	-$1.07B	-$188.20M	$2.45M	-$617.68M
EPS, basic	$2.16	$3.72	$2.35	-$3.88	-$1.72	-$0.16	$0.00	$0.29	-$9.45	-$1.96	-$0.08	-$5.28
EPS, diluted	$2.15	$3.52	$2.34	-$3.88	-$1.72	-$0.16	$0.00	$0.29	-$9.45	-$1.96	-$0.08	-$5.24
Diluted shares	118.5M	136.2M	118.6M	-	117.7M	117.7M	117.6M	-	117.5M	117.5M	117.5M	-

Balance sheet

Balance sheet
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Cash and equivalents	$1.85B	$1.63B	$1.09B	$1.62B	$1.93B	$1.81B	$1.52B	$1.19B	$1.66B	$1.83B	$2.06B	$889.90M
Receivables	$606.38M	$603.80M	$522.72M	$593.50M	$733.48M	$766.43M	$670.77M	$742.20M	$749.79M	$785.55M	$874.04M	$1.21B
Inventory	$1.39B	$1.38B	$1.35B	$1.18B	$1.53B	$1.64B	$1.66B	$1.50B	$1.66B	$1.80B	$1.90B	$2.16B
Current assets	$4.23B	$3.94B	$3.26B	$4.01B	$4.55B	$4.51B	$4.11B	$3.84B	$4.67B	$5.23B	$5.82B	$5.22B
Goodwill	$1.49B	$1.48B	$1.49B	$1.50B	$1.49B	$1.67B	$1.61B	$1.58B	$1.64B	$1.60B	$1.61B	$1.63B
Total assets	$16.08B	$15.91B	$15.14B	$16.37B	$17.15B	$17.29B	$17.00B	$16.61B	$17.46B	$18.39B	$19.03B	$18.27B
Current liabilities	$1.81B	$1.89B	$1.58B	$1.80B	$2.00B	$1.95B	$1.94B	$1.97B	$1.91B	$1.96B	$2.05B	$3.56B
Short-term debt	$74.60M	$74.68M	$74.63M	$74.08M	$445.38M	$444.91M	$410.48M	$398.02M	$3.01M	$3.21M	$5.08M	$625.76M
Long-term debt	$1.81B	$1.80B	$1.81B	$3.12B	$3.18B	$3.18B	$3.13B	$3.12B	$3.57B	$3.52B	$3.52B	$3.54B
Total debt	$1.88B	$1.88B	$1.88B	$3.19B	$3.63B	$3.62B	$3.54B	$3.52B	$3.57B	$3.52B	$3.52B	$4.17B
Total liabilities	$5.26B	$5.37B	$5.03B	$6.59B	$6.88B	$6.79B	$6.72B	$6.41B	$6.96B	$6.91B	$7.23B	$8.61B
Shareholders' equity	$10.54B	$10.53B	$10.11B	$9.53B	$10.27B	$10.50B	$10.27B	$10.20B	$10.49B	$11.48B	$11.80B	$9.67B

Cash flow

Cash flow
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Operating cash flow	$405.80M	$710.00M	$346.24M	$388.49M	$355.60M	-$9.03M	$547.21M	-$4.38M	$227.11M	$367.66M	$97.48M	-$96.96M
Capital expenditures	$80.37M	$71.73M	$98.68M	$155.38M	$132.16M	$119.63M	$182.62M	$342.81M	$303.13M	$451.55M	$583.04M	$689.35M
Free cash flow	$325.42M	$638.27M	$247.57M	$233.10M	$223.44M	-$128.66M	$364.58M	-$347.19M	-$76.02M	-$83.89M	-$485.56M	-$786.31M
Investing cash flow	-$85.57M	-$80.44M	$540.96M	-$176.64M	-$152.98M	$312.67M	-$129.06M	-$328.53M	-$317.07M	-$459.17M	-$480.00M	-$848.94M
Financing cash flow	-$109.46M	-$80.05M	-$1.41B	-$533.02M	-$90.53M	-$90.63M	-$120.01M	-$92.88M	-$109.97M	-$112.72M	$1.56B	$397.00M
Dividends paid	$47.79M	$47.70M	$47.67M	$47.63M	$47.66M	$47.64M	$47.61M	$47.60M	$47.01M	$47.01M	$46.91M	$46.94M
Stock-based compensation	$9.56M	$6.78M	$7.88M	$12.22M	$10.98M	$10.10M	$6.97M	$7.70M	$9.00M	$6.12M	$9.32M	$7.08M
Depreciation and amortization	$168.40M	$155.80M	$157.81M	$163.71M	$164.48M	$168.73M	$161.75M	$163.11M	$163.50M	$138.28M	$123.75M	$144.14M

Key ratios

Key ratios
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue growth, YoY	18.8%	31.1%	32.7%	15.9%	-3.5%	-7.0%	-20.9%	-47.7%	-41.4%	-39.7%	-47.3%	-10.1%
Net income growth, YoY	-	1996.2%	671.7%	-	-	-	1589.1%	-	-	-	-99.8%	-
Gross margin	19.4%	33.9%	35.1%	13.9%	9.0%	14.8%	14.5%	11.2%	-7.7%	-0.7%	2.9%	-29.9%
Operating margin	9.5%	26.0%	16.3%	-15.2%	-16.6%	3.6%	1.8%	0.4%	-81.9%	-34.4%	-13.2%	-36.1%
Net margin	19.1%	27.5%	22.3%	-29.0%	-12.3%	1.7%	3.8%	6.1%	-78.9%	-13.2%	0.2%	-26.2%
Free cash flow margin	21.0%	36.6%	17.3%	16.3%	17.1%	-9.7%	33.9%	-28.2%	-5.6%	-5.9%	-35.7%	-33.4%
Current ratio	2.34	2.09	2.07	2.23	2.27	2.31	2.11	1.95	2.44	2.67	2.84	1.47
Debt to equity	0.18	0.18	0.19	0.33	0.35	0.35	0.34	0.34	0.34	0.31	0.30	0.43

Source: XBRL data Albemarle Corporation files with the SEC, latest filing dated Nov 4, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

ALB peers

Company	Revenue	Growth	Net income	Net margin	Market cap
ALB	$6.15B	+24.4%	$681.63M	11.1%	$11.71B
LINLinde plc	$36.24B	+8.2%	$7.01B	19.3%	$236.54B
APDAir Products and Chemicals Inc.	$12.60B	+4.5%	-$47.30M	-0.4%	$67.88B
DOWDow Inc.	$42.61B	+4.2%	-$897.00M	-2.1%	$22.73B
IFFInternational Flavors & Fragrances Inc.	$11.69B	+24.3%	$182.00M	1.6%	$20.69B
LYBLyondellBasell Industries NV	$31.96B	+3.5%	$1.30B	4.1%	$19.63B
DDDuPont de Nemours Inc.	$7.06B	+3.2%	$301.00M	4.3%	$19.42B
SOLSSolstice Advanced Materials Inc.	$4.17B	+9.4%	$325.00M	7.8%	$9.12B
WLKWestlake Corporation	$11.44B	-0.4%	-$424.00M	-3.7%	$8.12B

ALB FAQ

9 questions

What is ALB revenue?
Albemarle Corporation (ALB) reported $6.15B of revenue for the twelve months ended Sep 30, 2026. That is up 24.4% from the year before. Revenue for fiscal 2025 was $5.14B.
Is ALB profitable?
Yes. Albemarle Corporation earned $681.63M in net income for the twelve months ended Sep 30, 2026, a net margin of 11.1%.
How much cash and debt does ALB have?
Albemarle Corporation reported $1.85B in cash and cash equivalents and $1.88B of debt on its most recent balance sheet in SEC filings.
How fast is ALB revenue growing?
Albemarle Corporation's revenue changed -4.4% in fiscal 2025, to $5.14B. Its compound annual growth rate was +10.4% over 5 years and +6.2% over 10 years.
What is ALB gross margin?
Albemarle Corporation's gross profit was $1.59B on $6.15B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 25.8%.
What is ALB free cash flow?
Albemarle Corporation generated $1.44B of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $1.85B less capital expenditures.
What is ALB earnings per share?
Diluted earnings per share were $4.13 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
When did ALB last report financial results?
The latest statements here come from Albemarle Corporation's 10-Q filed on Nov 4, 2026, covering the period ended Sep 30, 2026.
Where does this ALB financial data come from?
Quantisnow builds these statements from the structured XBRL data Albemarle Corporation files with the SEC. It is provided for information only and is not investment advice.